Published Date：Nov. 2020
Industry：Medical Devices & Consumables
Pages：119 Table Number：131
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Peptides and Heparin market in this environment. In terms of revenue, this research report indicated that the global Peptides and Heparin market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Peptides and Heparin industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Cipla Ltd. aims at producing XX Peptides and Heparin in 2020, with XX % production to take place in global market, ????Emcure Pharmaceuticals Pvt. Ltd. accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Peptides and Heparin Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Peptides and Heparin Market? Cipla Ltd. Emcure Pharmaceuticals Pvt. Ltd. Gland Pharma Limited Troikaa Pharmaceuticals Ltd. Biological E Limited Bharat Biotech Samarth Life Sciences Pvt. Ltd. VHB Life Sciences Limited Celon Laboratories Pvt. Ltd. United Biotech (P) Limited Biocon Limited Sun Pharmaceutical Industries Ltd. Wockhardt Ltd. ... Major Type of Peptides and Heparin Covered in XYZResearch report: Insulin Teriparatide Liraglutide Leuprolide Leuprolide Exenatide Calcitonin Enaxaparin Sodium Heparin Sodium Application Segments Covered in XYZResearch Market Diabetes Infectious Diseases Cancer Osteoporosis For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Peptides and Heparin Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Insulin -Product Introduction and Major Manufacturers 1.1.2 Teriparatide -Product Introduction and Major Manufacturers 1.1.3 Liraglutide -Product Introduction and Major Manufacturers 1.1.4 Leuprolide -Product Introduction and Major Manufacturers 1.1.5 Leuprolide -Product Introduction and Major Manufacturers 1.1.6 Exenatide -Product Introduction and Major Manufacturers 1.1.7 Calcitonin -Product Introduction and Major Manufacturers 1.1.8 Enaxaparin Sodium -Product Introduction and Major Manufacturers 1.1.9 Heparin Sodium -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Peptides and Heparin Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Peptides and Heparin Market 3.1.1 Top Companies leading Peptides and Heparin Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Peptides and Heparin Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Peptides and Heparin Market 3.2.1 Top Companies leading Peptides and Heparin Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Peptides and Heparin Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Peptides and Heparin Market 3.3.1 Top Companies leading Peptides and Heparin Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Peptides and Heparin Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Peptides and Heparin Market 3.4.1 Top Companies leading Peptides and Heparin Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Peptides and Heparin Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Peptides and Heparin Market 3.5.1 Top Companies leading Peptides and Heparin Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Peptides and Heparin Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Peptides and Heparin Market 3.6.1 Top Companies leading Peptides and Heparin Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Peptides and Heparin Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Peptides and Heparin Market 3.7.1 Top Companies leading Peptides and Heparin Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Peptides and Heparin Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Peptides and Heparin Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Peptides and Heparin Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Peptides and Heparin Sales and Growth Rate (2021-2026) 5.2 Global Peptides and Heparin Sales Value and Growth Rate (2021-2026) 6 Peptides and Heparin Competitive Analysis 6.1 Cipla Ltd. 6.1.1 Cipla Ltd. Company Profiles 6.1.2 Cipla Ltd. Product Introduction 6.1.3 Cipla Ltd. Peptides and Heparin Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Emcure Pharmaceuticals Pvt. Ltd. 6.2.1 Emcure Pharmaceuticals Pvt. Ltd. Company Profiles 6.2.2 Emcure Pharmaceuticals Pvt. Ltd. Product Introduction 6.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Gland Pharma Limited 6.3.1 Gland Pharma Limited Company Profiles 6.3.2 Gland Pharma Limited Product Introduction 6.3.3 Gland Pharma Limited Peptides and Heparin Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Troikaa Pharmaceuticals Ltd. 6.4.1 Troikaa Pharmaceuticals Ltd. Company Profiles 6.4.2 Troikaa Pharmaceuticals Ltd. Product Introduction 6.4.3 Troikaa Pharmaceuticals Ltd. Peptides and Heparin Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 Biological E Limited 6.5.1 Biological E Limited Company Profiles 6.5.2 Biological E Limited Product Introduction 6.5.3 Biological E Limited Peptides and Heparin Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 Bharat Biotech 6.6.1 Bharat Biotech Company Profiles 6.6.2 Bharat Biotech Product Introduction 6.6.3 Bharat Biotech Peptides and Heparin Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 Samarth Life Sciences Pvt. Ltd. 6.7.1 Samarth Life Sciences Pvt. Ltd. Company Profiles 6.7.2 Samarth Life Sciences Pvt. Ltd. Product Introduction 6.7.3 Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 VHB Life Sciences Limited 6.8.1 VHB Life Sciences Limited Company Profiles 6.8.2 VHB Life Sciences Limited Product Introduction 6.8.3 VHB Life Sciences Limited Peptides and Heparin Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 6.9 Celon Laboratories Pvt. Ltd. 6.9.1 Celon Laboratories Pvt. Ltd. Company Profiles 6.9.2 Celon Laboratories Pvt. Ltd. Product Introduction 6.9.3 Celon Laboratories Pvt. Ltd. Peptides and Heparin Production, Revenue (2015-2020) 6.9.4 SWOT Analysis 6.10 United Biotech (P) Limited 6.10.1 United Biotech (P) Limited Company Profiles 6.10.2 United Biotech (P) Limited Product Introduction 6.10.3 United Biotech (P) Limited Peptides and Heparin Production, Revenue (2015-2020) 6.10.4 SWOT Analysis 6.11 Biocon Limited 6.12 Sun Pharmaceutical Industries Ltd. 6.13 Wockhardt Ltd. 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Peptides and Heparin Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Peptides and Heparin Sales (K Unit) by Type (2015-2026) Figure Global Peptides and Heparin Sales (K Unit) and Growth Rate (2015-2026) Figure Global Peptides and Heparin Sales Market Share (%) by Type (2019 -2020) Table Global Peptides and Heparin Sales Value (Million USD) by Type (2015-2026) Figure Global Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Peptides and Heparin Sales Value Market Share (%) by Type (2019-2020) Table Global Peptides and Heparin Sales (K Unit) by Application (2015-2026) Table China Peptides and Heparin Sales (K Unit) of Major Company (2015-2020) Table China Peptides and Heparin Sales Market Share of Major Company (2015-2020) Table China Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020) Figure China Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020) Table China Peptides and Heparin Sales Value Share of Major Company (2015-2020) Table China Peptides and Heparin Price (USD/Unit), by Type (2019-2020) Table China Peptides and Heparin Sales (Unit) by Type (2015-2026) Figure China Peptides and Heparin Sales (Unit) by Type (2015-2026) Table EU Peptides and Heparin Sales (K Unit) of Major Company (2015-2020) Table EU Peptides and Heparin Sales Market Share of Major Company (2015-2020) Table EU Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020) Figure EU Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Peptides and Heparin Sales Value Share of Major Company (2015-2020) Table EU Peptides and Heparin Price (USD/Unit), by Type (2019-2020) Table EU Peptides and Heparin Sales (Unit) by Type (2015-2026) Figure EU Peptides and Heparin Sales (Unit) by Type (2015-2026) Table USA Peptides and Heparin Sales (K Unit) of Major Company (2015-2020) Table USA Peptides and Heparin Sales Market Share of Major Company (2015-2020) Table USA Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020) Figure USA Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Peptides and Heparin Sales Value Share of Major Company (2015-2020) Table USA Peptides and Heparin Price (USD/Unit), by Type (2019-2020) Table USA Peptides and Heparin Sales (Unit) by Type (2015-2026) Figure USA Peptides and Heparin Sales (Unit) by Type (2015-2026) Table Japan Peptides and Heparin Sales (K Unit) of Major Company (2015-2020) Table Japan Peptides and Heparin Sales Market Share of Major Company (2015-2020) Table Japan Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Peptides and Heparin Sales Value Share of Major Company (2015-2020) Table Japan Peptides and Heparin Price (USD/Unit), by Type (2019-2020) Table Japan Peptides and Heparin Sales (Unit) by Type (2015-2026) Figure Japan Peptides and Heparin Sales (Unit) by Type (2015-2026) Table India Peptides and Heparin Sales (K Unit) of Major Company (2015-2020) Table India Peptides and Heparin Sales Market Share of Major Company (2015-2020) Table India Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020) Figure India Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020) Table India Peptides and Heparin Sales Value Share of Major Company (2015-2020) Table India Peptides and Heparin Price (USD/Unit), by Type (2019-2020) Table India Peptides and Heparin Sales (Unit) by Type (2015-2026) Figure India Peptides and Heparin Sales (Unit) by Type (2015-2026) Table Southeast Asia Peptides and Heparin Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Peptides and Heparin Sales Market Share of Major Company (2015-2020) Table Southeast Asia Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Peptides and Heparin Sales Value Share of Major Company (2015-2020) Table Southeast Asia Peptides and Heparin Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Peptides and Heparin Sales (Unit) by Type (2015-2026) Figure Southeast Asia Peptides and Heparin Sales (Unit) by Type (2015-2026) Table South America Peptides and Heparin Sales (K Unit) of Major Company (2015-2020) Table South America Peptides and Heparin Sales Market Share of Major Company (2015-2020) Table South America Peptides and Heparin Sales Value (Million USD) of Major Company (2015-2020) Figure South America Peptides and Heparin Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Peptides and Heparin Sales Value Share of Major Company (2015-2020) Table South America Peptides and Heparin Price (USD/Unit), by Type (2019-2020) Table South America Peptides and Heparin Sales (Unit) by Type (2015-2026) Figure South America Peptides and Heparin Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Peptides and Heparin Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Peptides and Heparin Figure Cost Structure of Peptides and Heparin in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Peptides and Heparin Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Peptides and Heparin Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table Cipla Ltd. Profiles Table Cipla Ltd. Peptides and Heparin Product Introduction Table Cipla Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Cipla Ltd. SWOT Analysis Table ????Emcure Pharmaceuticals Pvt. Ltd. Profiles Table ????Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Product Introduction Table ????Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Emcure Pharmaceuticals Pvt. Ltd. SWOT Analysis Table ????Gland Pharma Limited Profiles Table ????Gland Pharma Limited Peptides and Heparin Product Introduction Table ????Gland Pharma Limited Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Gland Pharma Limited SWOT Analysis Table ????Troikaa Pharmaceuticals Ltd. Profiles Table ????Troikaa Pharmaceuticals Ltd. Peptides and Heparin Product Introduction Table ????Troikaa Pharmaceuticals Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Troikaa Pharmaceuticals Ltd. SWOT Analysis Table ????Biological E Limited Profiles Table ????Biological E Limited Peptides and Heparin Product Introduction Table ????Biological E Limited Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Biological E Limited SWOT Analysis Table ????Bharat Biotech Profiles Table ????Bharat Biotech Peptides and Heparin Product Introduction Table ????Bharat Biotech Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Bharat Biotech SWOT Analysis Table ????Samarth Life Sciences Pvt. Ltd. Profiles Table ????Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Product Introduction Table ????Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Samarth Life Sciences Pvt. Ltd. SWOT Analysis Table ????VHB Life Sciences Limited Profiles Table ????VHB Life Sciences Limited Peptides and Heparin Product Introduction Table ????VHB Life Sciences Limited Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????VHB Life Sciences Limited SWOT Analysis Table ????Celon Laboratories Pvt. Ltd. Profiles Table ????Celon Laboratories Pvt. Ltd. Peptides and Heparin Product Introduction Table ????Celon Laboratories Pvt. Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Celon Laboratories Pvt. Ltd. SWOT Analysis Table ????United Biotech (P) Limited Profiles Table ????United Biotech (P) Limited Peptides and Heparin Product Introduction Table ????United Biotech (P) Limited Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????United Biotech (P) Limited SWOT Analysis Table ????Biocon Limited Profiles Table ????Biocon Limited Peptides and Heparin Product Introduction Table ????Biocon Limited Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Biocon Limited SWOT Analysis Table ????Sun Pharmaceutical Industries Ltd. Profiles Table ????Sun Pharmaceutical Industries Ltd. Peptides and Heparin Product Introduction Table ????Sun Pharmaceutical Industries Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Sun Pharmaceutical Industries Ltd. SWOT Analysis Table ????Wockhardt Ltd. Profiles Table ????Wockhardt Ltd. Peptides and Heparin Product Introduction Table ????Wockhardt Ltd. Peptides and Heparin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
